Belpointe Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.89M | Buy |
30,259
+3,591
| +13% | +$420K | 0.13% | 146 |
|
|
2026
Q1 | $3.21M | Buy |
26,668
+12,661
| +90% | +$1.46M | 0.12% | 165 |
|
|
2025
Q4 | $1.47M | Sell |
14,007
-980
| -7% | -$92K | 0.05% | 301 |
|
|
2025
Q3 | $1.26M | Buy |
14,987
+1,557
| +12% | +$128K | 0.05% | 337 |
|
|
2025
Q2 | $1.06M | Sell |
13,430
-806
| -6% | -$64.1K | 0.04% | 341 |
|
|
2025
Q1 | $1.28M | Buy |
14,236
+1,476
| +12% | +$138K | 0.07% | 278 |
|
|
2024
Q4 | $1.51M | Buy |
12,760
+158
| +1% | +$16.3K | 0.09% | 222 |
|
|
2024
Q3 | $1.43M | Sell |
12,602
-2,498
| -17% | -$297K | 0.09% | 231 |
|
|
2024
Q2 | $1.87M | Buy |
15,100
+1,137
| +8% | +$146K | 0.13% | 150 |
|
|
2024
Q1 | $1.84M | Buy |
13,963
+462
| +3% | +$56.9K | 0.14% | 140 |
|
|
2023
Q4 | $1.47M | Sell |
13,501
-1,829
| -12% | -$190K | 0.13% | 158 |
|
|
2023
Q3 | $1.58M | Sell |
15,330
-906
| -6% | -$97.7K | 0.16% | 127 |
|
|
2023
Q2 | $1.87M | Sell |
16,236
-29,359
| -64% | -$3.33M | 0.2% | 102 |
|
|
2023
Q1 | $4.85M | Sell |
45,595
-5,983
| -12% | -$646K | 0.26% | 62 |
|
|
2022
Q4 | $5.72M | Buy |
51,578
+10,847
| +27% | +$1.11M | 0.35% | 48 |
|
|
2022
Q3 | $3.51M | Buy |
40,731
+3,923
| +11% | +$350K | 0.24% | 78 |
|
|
2022
Q2 | $3.36M | Sell |
36,808
-7,382
| -17% | -$654K | 0.23% | 91 |
|
|
2022
Q1 | $3.62M | Buy |
44,190
+9,534
| +28% | +$752K | 0.22% | 84 |
|
|
2021
Q4 | $2.66M | Buy |
34,656
+121
| +0.4% | +$9.64K | 0.17% | 124 |
|
|
2021
Q3 | $2.59M | Buy |
34,535
+2,224
| +7% | +$169K | 0.18% | 120 |
|
|
2021
Q2 | $2.51M | Buy |
32,311
+1,312
| +4% | +$97.6K | 0.18% | 120 |
|
|
2021
Q1 | $2.28M | Sell |
30,999
-754
| -2% | -$55.6K | 0.2% | 108 |
|
|
2020
Q4 | $2.48M | Buy |
31,753
+9,710
| +44% | +$743K | 0.22% | 101 |
|
|
2020
Q3 | $1.75M | Sell |
22,043
-1
| -0% | -$78 | 0.19% | 111 |
|
|
2020
Q2 | $1.63M | Sell |
22,044
-6,635
| -23% | -$499K | 0.21% | 98 |
|
|
2020
Q1 | $2.1M | Sell |
28,679
-902
| -3% | -$70.9K | 0.37% | 60 |
|
|
2019
Q4 | $2.57M | Buy |
29,581
+7,242
| +32% | +$595K | 0.33% | 78 |
|
|
2019
Q3 | $1.79M | Buy |
22,339
+2,082
| +10% | +$167K | 0.29% | 80 |
|
|
2019
Q2 | $1.62M | Buy |
20,257
+2,999
| +17% | +$230K | 0.32% | 68 |
|
|
2019
Q1 | $1.37M | Buy |
17,258
+5,789
| +50% | +$433K | 0.27% | 60 |
|
|
2018
Q4 | $836K | Sell |
11,469
-3,758
| -25% | -$265K | 0.21% | 101 |
|
|
2018
Q3 | $1.03M | Buy |
15,227
+6,756
| +80% | +$430K | 0.16% | 117 |
|
|
2018
Q2 | $491K | Sell |
8,471
-78
| -0.9% | -$4.4K | 0.14% | 170 |
|
|
2018
Q1 | $444K | Buy |
8,549
+1,496
| +21% | +$80.8K | 0.13% | 185 |
|
|
2017
Q4 | $379K | Sell |
7,053
-1,292
| -15% | -$71.6K | 0.08% | 289 |
|
|
2017
Q3 | $510K | Buy |
+8,345
| New | +$506K | 0.12% | 185 |
|
Other funds holding MRK
ECSS
Belpointe Asset Management's MRK Position: Q2 2026 in Review
Belpointe Asset Management increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $420K and bringing the position to 30,259 shares worth $3.89M. The position accounts for 0.13% of the portfolio, ranked #146.
Belpointe Asset Management first reported a position in MRK in Q3 2017 and has held it in 36 quarters since. The position peaked at $5.72M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Belpointe Asset Management held 30,259 shares of Merck worth $3.89M as of Q2 2026.
- Belpointe Asset Management bought 3,591 Merck shares in Q2 2026, an estimated $420K.
- Merck made up 0.13% of Belpointe Asset Management's portfolio in Q2 2026, its #146 holding.
- Belpointe Asset Management first reported a position in Merck in Q3 2017 and has held it in 36 quarters since.
- Belpointe Asset Management's Merck position peaked at $5.72M in Q4 2022.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.